
| Administration | Basic Sciences | Clinical Sciences | Centers of Excellence |
|---|---|---|---|
|
The scope of Program research ranges from the development of gene-based strategies for prevention or therapy of intractable infectious diseases and different cancers, to the restoration of missing function in genetic disease. These translational programs are underpinned by strong fundamental research in vector development, gene discovery, and clarification of underlying disease mechanisms. Our aim is to develop novel preventives and therapies for several common diseases and conditions, including HIV/AIDS, tuberculosis, cystic fibrosis, Krabbe's Disease, and asthma, as well as cancers of the breast, lung and prostate.
Dr. Alistair Ramsay: Genetic Vaccines for Infectious Disease and Cancer
Dr. Jakob Reiser: The Use of Viral Vector Mediated Gene Delivery and Stem Cell Engineering in Gene-Based and Cell-Based Therapies.
Dr. Yan Cui: Immunotherapy of Cancer using Engineered Hematopoietic Cells
Dr. Guoshon Wang: Neutrophils in Cystic Fibrosis
Dr. Pamela Kozlowski: HIV vaccine development,HIV pathogenesis and mucosal immunity to HIV.
Dr. Xianyang Zhang: Design of improved lentiviral vectors for gene delivery
Dr. Doan Nguyen: Lacrimal Gland Bioinformatics: A Neural Connection of Dry Eye and Aging